Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration

Anat Loewenstein; Guna Laganovska; Neil M. Bressler; Juris Vanags; Yair Alster; Eugene De Juan; Jay M. Stewart; David Kardatzke; Natasha Singh; Signe Erickson

Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration

Anat Loewenstein, Guna Laganovska, Neil M. Bressler, Juris Vanags, Yair Alster, Eugene De Juan, Jay M. Stewart, David Kardatzke, Natasha Singh, Signe Erickson

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Investigative Ophthalmology and Visual Science
Volume	61
Issue number	7
Publication status	Published - Jun 2020
Externally published	Yes
Event	Annual Meeting of the Association for Research in Vision and Ophthalmology - Baltimore, United States Duration: 3 May 2020 → 7 May 2020

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

https://iovs.arvojournals.org/article.aspx?articleid=2769145&resultClick=1Licence: CC BY-NC-ND

Cite this

Loewenstein, A., Laganovska, G., Bressler, N. M., Vanags, J., Alster, Y., De Juan, E., Stewart, J. M., Kardatzke, D., Singh, N., & Erickson, S. (2020). Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science, 61(7). https://iovs.arvojournals.org/article.aspx?articleid=2769145&resultClick=1

@article{4b9b544fbd6348f8b6c28ab8d427059d,

title = "Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration",

author = "Anat Loewenstein and Guna Laganovska and Bressler, \{Neil M.\} and Juris Vanags and Yair Alster and \{De Juan\}, Eugene and Stewart, \{Jay M.\} and David Kardatzke and Natasha Singh and Signe Erickson",

year = "2020",

month = jun,

language = "English",

volume = "61",

journal = "Investigative Ophthalmology and Visual Science",

issn = "0146-0404",

publisher = "Association for Research in Vision and Ophthalmology Inc.",

number = "7",

note = "Annual Meeting of the Association for Research in Vision and Ophthalmology, ARVO ; Conference date: 03-05-2020 Through 07-05-2020",

}

Loewenstein, A, Laganovska, G, Bressler, NM, Vanags, J, Alster, Y, De Juan, E, Stewart, JM, Kardatzke, D, Singh, N & Erickson, S 2020, 'Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration', Investigative Ophthalmology and Visual Science, vol. 61, no. 7. <https://iovs.arvojournals.org/article.aspx?articleid=2769145&resultClick=1>

TY - JOUR

T1 - Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration

AU - Loewenstein, Anat

AU - Laganovska, Guna

AU - Bressler, Neil M.

AU - Vanags, Juris

AU - Alster, Yair

AU - De Juan, Eugene

AU - Stewart, Jay M.

AU - Kardatzke, David

AU - Singh, Natasha

AU - Erickson, Signe

PY - 2020/6

Y1 - 2020/6

M3 - Meeting Abstract

SN - 0146-0404

VL - 61

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

IS - 7

T2 - Annual Meeting of the Association for Research in Vision and Ophthalmology

Y2 - 3 May 2020 through 7 May 2020

ER -